Jennifer Williams

2 days ago | businesswire.com | Jennifer Williams

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended March 31, 2025, on Thursday, May 15, 2025, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.

3 days ago | businesswire.com | Jennifer Williams

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) today announced that it has entered into exchange agreements (the “Exchange Agreements”) with a limited number of investors who are holders of the Company’s 5.25% Convertible Senior Notes due 2026 (the “2026 Convertible Notes”) to exchange, on a one-for-one basis, $70.5 million aggregate principal amount of the 2026 Convertible Notes for newly issued 9.50% Convertible Senior Notes due 2029, with a...

1 week ago | finance.yahoo.com | Jennifer Williams

Cutting more than half of its Amazon deliveries is good for UPS’s business in the long run, its CFO says.

1 week ago | wsj.com | Jennifer Williams

“The world changed tremendously,” Brian Dykes said. “But the actions we’re taking with Amazon, they are all about giving us more control over our financial outcome.”Dykes said the decision to cut more than half of its delivery business with Amazon by June 2026 was years in the making. A main motivation was finding a way to deliver packages that is more profitable. The answer: Cutting back on lighter deliveries that travel short distances.

1 week ago | businesswire.com | Jennifer Williams

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA).